Back to 
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
KNTEShowing 0 of 15 quarters
Position history for GEODE CAPITAL MANAGEMENT, LLC's holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, Geode Capital Management held 244,151 shares of KNTE (Kinnate Biopharma), worth $649,569. Geode Capital Management's 13F filings listed KNTE from Q4 2020 to Q1 2024, 14 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., FMR LLC